一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223523 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223534 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-07-30 08:35
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026635 Size: 43 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223540 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223522 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223516 Size: 21 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-08-16 AccNo: 0001193125-19-223545 Size: 10 KB 网页链接查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223513 Size: 21 KB 网页链接查看全文
E药经理人2022-10-29 00:00
以FIC估值或判断一家公司的成功与否有时也许是一个“悖论”。不能否认技术与商业之间的确存在矛盾,但真正的好药一定是追求科学价值的同时能够兑现其商业价值的。
一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen, Inc.(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-05-07 AccNo: 0000921895-18-001591 Size: 150 KB 网页链接
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-05-03,10% Owner,DUGGAN ROBERT W ,买入,130255普通股, $11.46
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-05-03,10% Owner,DUGGAN ROBERT W ,买入,846625普通股, $11.31
$Achaogen, Inc.(AKAO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-07 AccNo: 0001564590-18-011139 Size: 8 MB 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2018-05-04 AccNo: 0001193125-18-151615 Size: 76 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2018-05-03 AccNo: 0001193125-18-149223 Size: 17 KBItem 8.01: Other Events 网页链接
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-04-27,10% Owner,DUGGAN ROBERT W ,买入,102849普通股, $12.96
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-04-26,10% Owner,DUGGAN ROBERT W ,买入,50000普通股, $12.96
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-04-25,10% Owner,DUGGAN ROBERT W ,买入,77247普通股, $13.02
$Achaogen, Inc.(AKAO)$ 美东时间 2018-05-04 盘前 披露财报,预期EPS -0.91 网页链接